CS logo
small CS logo
New England Center for Clinical Research

Cranston, Rhode Island, United States
Research institute in Fall River, Massachusetts
277 Pleasant St, Bld 1, Suite 204, Fall River, MA 02721

About New England Center for Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at New England Center for Clinical Research


During the past decade, New England Center for Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
2006-06-01
2011-07-01
Completed
41
S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
2007-03-01
2014-01-01
Completed
85
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
2007-07-01
2014-01-01
Completed
89
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
2008-03-01
2014-02-25
Completed
134
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014

Rows per page:

1–100 of 289

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "New England Center for Clinical Research" #1 sponsor was "Purdue Pharma LP" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "BioCryst Pharmaceuticals" with 3 trials sponsored, "Novartis" with 2 trials sponsored and "Zogenix, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "New England Center for Clinical Research" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "VertiFlex, Incorporated" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at New England Center for Clinical Research


According to Clinical.Site data, the most researched conditions in "New England Center for Clinical Research" are "Low Back Pain" (5 trials), "Back Pain Lower Back Chronic" (3 trials), "Chronic Pain" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Influenza" (2 trials). Many other conditions were trialed in "New England Center for Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at New England Center for Clinical Research


Most popular intervention types in "New England Center for Clinical Research" are "Drug" (22 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Naproxen" (3 trials), "Buprenorphine" (2 trials), "Buprenorphine transdermal patch" (2 trials) and "Peramivir" (2 trials). Other intervention names were less common.

Clinical Trials Genders at New England Center for Clinical Research


The vast majority of trials in "New England Center for Clinical Research" are 24 trials for "All" genders.

Clinical Trials Status at New England Center for Clinical Research


Currently, there are NaN active trials in "New England Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in New England Center for Clinical Research, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in New England Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status